These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16336980)

  • 1. Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.
    Nizri E; Hamra-Amitay Y; Sicsic C; Lavon I; Brenner T
    Neuropharmacology; 2006 Apr; 50(5):540-7. PubMed ID: 16336980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.
    Brenner T; Nizri E; Irony-Tur-Sinai M; Hamra-Amitay Y; Wirguin I
    J Neuroimmunol; 2008 Sep; 201-202():121-7. PubMed ID: 18684515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished antigen-specific IgG1 and interleukin-6 production and acetylcholinesterase expression in combined M1 and M5 muscarinic acetylcholine receptor knockout mice.
    Fujii YX; Tashiro A; Arimoto K; Fujigaya H; Moriwaki Y; Misawa H; Fujii T; Matsui M; Kasahara T; Kawashima K
    J Neuroimmunol; 2007 Aug; 188(1-2):80-5. PubMed ID: 17586055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients.
    Reale M; Iarlori C; Gambi F; Feliciani C; Isabella L; Gambi D
    Neuropharmacology; 2006 Apr; 50(5):606-13. PubMed ID: 16445950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production.
    Pollak Y; Gilboa A; Ben-Menachem O; Ben-Hur T; Soreq H; Yirmiya R
    Ann Neurol; 2005 May; 57(5):741-5. PubMed ID: 15852394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines.
    Reale M; Iarlori C; Gambi F; Feliciani C; Salone A; Toma L; DeLuca G; Salvatore M; Conti P; Gambi D
    J Neuroimmunol; 2004 Mar; 148(1-2):162-71. PubMed ID: 14975597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity.
    Nizri E; Irony-Tur-Sinai M; Lavon I; Meshulam H; Amitai G; Brenner T
    Int Immunopharmacol; 2007 Sep; 7(9):1129-39. PubMed ID: 17630191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Wang Y; Mei Y; Feng D; Xu L
    J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis.
    Kleiter I; Pedré X; Mueller AM; Poeschl P; Couillard-Despres S; Spruss T; Bogdahn U; Giegerich G; Steinbrecher A
    J Neuroimmunol; 2007 Jul; 187(1-2):61-73. PubMed ID: 17553571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro investigation of the effects of the nerve agent pretreatment pyridostigmine bromide on human peripheral blood T-cell function.
    Telford G; Wilkinson LJ; Hooi DS; Worrall V; Green AC; Cook DL; Pritchard DI; Griffiths GD
    Int Immunopharmacol; 2004 Nov; 4(12):1455-66. PubMed ID: 15351315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cholinergic balance perturbation in neurological diseases.
    Nizri E; Wirguin I; Brenner T
    Drug News Perspect; 2007 Sep; 20(7):421-9. PubMed ID: 17992264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
    Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-sense approach to anticholinesterase therapeutics.
    Soreq H; Seidman S
    Isr Med Assoc J; 2000 Jul; 2 Suppl():81-5. PubMed ID: 10909423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis.
    Brenner T; Hamra-Amitay Y; Evron T; Boneva N; Seidman S; Soreq H
    FASEB J; 2003 Feb; 17(2):214-22. PubMed ID: 12554700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulated-single fiber electromyography monitoring of anti-sense induced changes in experimental autoimmune myasthenia gravis.
    Boneva N; Hamra-Amitay Y; Wirguin I; Brenner T
    Neurosci Res; 2006 May; 55(1):40-4. PubMed ID: 16504322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-targeted suppression of stress-induced allostasis in primate spinal cord neurons.
    Evron T; Moyal-Segal LB; Lamm N; Geffen A; Soreq H
    Neurodegener Dis; 2005; 2(1):16-27. PubMed ID: 16908999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase inhibitors in MG: to be or not to be?
    Punga AR; Stålberg E
    Muscle Nerve; 2009 Jun; 39(6):724-8. PubMed ID: 19260048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats.
    Zimmerman G; Njunting M; Ivens S; Tolner EA; Behrens CJ; Gross M; Soreq H; Heinemann U; Friedman A
    Eur J Neurosci; 2008 Feb; 27(4):965-75. PubMed ID: 18333967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral site acetylcholinesterase blockade induces RACK1-associated neuronal remodeling.
    Farchi N; Ofek K; Podoly E; Dong H; Xiang YY; Diamant S; Livnah O; Li J; Hochner B; Lu WY; Soreq H
    Neurodegener Dis; 2007; 4(2-3):171-84. PubMed ID: 17596712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.